APA (7th ed.) Citation

Zhu, H., Feng, J., Xiang, Y., Wang, K., Zhou, L., Liu, Z., . . . Cheng, S. (2023). Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-11003-0

Chicago Style (17th ed.) Citation

Zhu, Hong-Fei, et al. "Combination of Alpha-fetoprotein and Neutrophil-to-lymphocyte Ratio to Predict Treatment Response and Survival Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-11003-0.

MLA (9th ed.) Citation

Zhu, Hong-Fei, et al. "Combination of Alpha-fetoprotein and Neutrophil-to-lymphocyte Ratio to Predict Treatment Response and Survival Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-11003-0.